Choosing the most appropriate treatment for stable angina. Safety considerations (Q39446259)

12 September 2017

1 reference

title

Choosing the most appropriate treatment for stable angina. Safety considerations (English)

1 reference

12 September 2017

S Asirvatham

1

1 reference

12 September 2017

C Sebastian

series ordinal

2

1 reference

12 September 2017

U Thadani

series ordinal

3

1 reference

12 September 2017

language of work or name

1 reference

1 July 1998

1 reference

12 September 2017

1 reference

12 September 2017

19

1 reference

12 September 2017

23-44

1 reference

12 September 2017

1

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-199819010-00003

12 September 2017

0 references

cites work

Benefits and risks of HMG-CoA reductase inhibitors in the prevention of coronary heart disease: a reappraisal

1 reference

12 December 2020

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

12 December 2020

Calcium channel blockers

1 reference

12 December 2020

Hormone therapy to prevent disease and prolong life in postmenopausal women

1 reference

12 December 2020

The menopause, hormone replacement, and cardiovascular disease: the epidemiologic evidence

1 reference

12 December 2020

Vitamin E consumption and the risk of coronary disease in women.

1 reference

12 December 2020

Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group

1 reference

12 December 2020

The Trial of Antihypertensive Interventions and Management (TAIM) Study. Final results with regard to blood pressure, cardiovascular risk, and quality of life

1 reference

12 December 2020

Epidemiologic studies of coronary heart disease: two approaches

1 reference

12 December 2020

Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women

1 reference

12 December 2020

Role of biologically modified low-density lipoprotein in atherosclerosis

1 reference

12 December 2020

Human vascular smooth muscle cells contain functional estrogen receptor

1 reference

12 December 2020

Postmenopausal hormone replacement therapy and cardiovascular risk reduction. A review.

1 reference

12 December 2020

Clinical perspectives on primary and secondary prevention of coronary atherosclerosis.

1 reference

12 December 2020

Transdermal isosorbide dinitrate in angina pectoris: effect of acute and sustained therapy

1 reference

12 December 2020

Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris

1 reference

12 December 2020

The prognosis in stable and unstable angina

1 reference

12 December 2020

Aspirin as a therapeutic agent in cardiovascular disease. Special Writing Group

1 reference

12 December 2020

The primary prevention of coronary heart disease in women

1 reference

12 December 2020

Hemodynamic tolerability and anti-ischemic efficacy of high dose intravenous diltiazem in patients with normal versus impaired ventricular function.

1 reference

12 December 2020

Lipid-lowering interventions in angiographic trials

1 reference

12 December 2020

Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure

1 reference

12 December 2020

An update on coronary risk factors.

1 reference

12 December 2020

Combined use of calcium-channel and beta-adrenergic blockers for the treatment of chronic stable angina. Rationale, efficacy, and adverse effects

1 reference

12 December 2020

Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration

1 reference

12 December 2020

Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin

1 reference

12 December 2020

Antioxidant vitamins, cancer, and cardiovascular disease

1 reference

12 December 2020

Dose-response evaluation of once-daily therapy with a new formulation of diltiazem for stable angina pectoris. Diltiazem CD Study Group

1 reference

12 December 2020

Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women

1 reference

12 December 2020

Contemporary approaches in medical management of patients with stable coronary artery disease.

1 reference

12 December 2020

Nonlipid primary and secondary prevention strategies for coronary heart disease

1 reference

12 December 2020

Beta-blockers in hypertensive and coronary heart disease

1 reference

12 December 2020

Effects of ACE inhibitors on coronary haemodynamics and angina pectoris

1 reference

12 December 2020

The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects

1 reference

12 December 2020

Chronic stable angina pectoris. Strategies for effective drug therapy

1 reference

12 December 2020

A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke

1 reference

12 December 2020

Nitrate therapy in the elderly

1 reference

12 December 2020

The efficacy of amlodipine in myocardial ischemia

1 reference

12 December 2020

Eighteen-year follow-up in the Veterans Affairs Cooperative Study of Coronary Artery Bypass Surgery for stable angina

1 reference

12 December 2020

1 reference

12 December 2020

Is aspirin safe for patients with heart failure?

1 reference

12 December 2020

Oral isosorbide dinitrate in angina pectoris: comparison of duration of action an dose-response relation during acute and sustained therapy

1 reference

12 December 2020

Primary prevention of coronary heart disease with drug therapy. Safety and total mortality issues

1 reference

12 December 2020

Short and long-acting oral nitrates for stable angina pectoris

1 reference

12 December 2020

Ongoing clinical trials of angiotensin-converting enzyme inhibitors for treatment of coronary artery disease in patients with preserved left ventricular function

1 reference

12 December 2020

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

1 reference

12 December 2020

Postmenopausal estrogen and prevention bias

1 reference

12 December 2020

Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study

1 reference

12 December 2020

Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia

1 reference

12 December 2020

Nitrate therapy for myocardial ischemic syndrome: current perspectives including tolerance

1 reference

12 December 2020

Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction

1 reference

12 December 2020

Pharmacologic prevention of coronary artery disease. What do clinical trials show?

1 reference

12 December 2020

Pathogenesis of angina pectoris and role of nitrates in relief of myocardial ischemia

1 reference

12 December 2020

Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)

1 reference

12 December 2020

Postmenopausal use of estrogen and occlusion of coronary arteries

1 reference

12 December 2020

Medical treatment of patients with severe exertional and rest angina: double blind comparison of beta blocker, calcium antagonist, and nitrate

1 reference

12 December 2020

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

1 reference

12 December 2020

Management of stable angina pectoris. Recommendations of the Task Force of the European Society of Cardiology

1 reference

12 December 2020

Lipid Research Clinics Coronary Primary Prevention Trial results

1 reference

12 December 2020

Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group

1 reference

12 December 2020

Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina

1 reference

12 December 2020

Low-dose aspirin therapy for chronic stable angina. A randomized, placebo-controlled clinical trial.

1 reference

12 December 2020

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

12 December 2020

Mechanisms of nitrate tolerance.

1 reference

12 December 2020

Prevalence and determinants of estrogen replacement therapy in elderly women.

1 reference

12 December 2020

Propranolol therapy in patients with acute myocardial infarction: the Beta-Blocker Heart Attack Trial

1 reference

12 December 2020

Trends in acute myocardial infarction and coronary heart disease death in the United States

1 reference

12 December 2020

Calcium channel antagonists in the treatment of coronary artery disease: fundamental pharmacological properties relevant to clinical use.

1 reference

12 December 2020

Pravastatin, lipids, and major coronary events

1 reference

12 December 2020

Ointments and transdermal nitroglycerin patches for stable angina pectoris

1 reference

12 December 2020

Drug therapy and the prevention of atherosclerosis in humans.

1 reference

12 December 2020

Effects of nitrates in various vascular sections and regions.

1 reference

12 December 2020

Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors. The Pravastatin Multinational Study Group for Cardiac Risk Patients

1 reference

12 December 2020

Nitrate tolerance, rebound, and their clinical relevance in stable angina pectoris, unstable angina, and heart failure

1 reference

12 December 2020

Asymptomatic Cardiac Ischemia Pilot (ACIP) study: outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization. The ACIP Investigators

1 reference

12 December 2020

1 reference

12 December 2020

Isradipine--another calcium-channel blocker for the treatment of hypertension and angina

1 reference

12 December 2020

Effects of the new calcium antagonist mibefradil (Ro 40-5967) on exercise duration in patients with chronic stable angina pectoris: a multicenter, placebo-controlled study. Ro 40-5967 International Study Group.

1 reference

12 December 2020

Exercise capacity after single and twice-daily doses of nicorandil in chronic stable angina pectoris

1 reference

12 December 2020

Ranolazine (RS-43285): a preliminary study of a new anti-anginal agent with selective effect on ischaemic myocardium

1 reference

12 December 2020

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

1 reference

12 December 2020

Management of myocardial ischemia: role of intermittent nitrate therapy

1 reference

12 December 2020

Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem

1 reference

12 December 2020

Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study

1 reference

12 December 2020

Angiotensin converting enzyme inhibition in chronic stable angina: effects on myocardial ischaemia and comparison with nifedipine

1 reference

12 December 2020

Antioxidants in adipose tissue and risk of myocardial infarction: the EURAMIC Study

1 reference

12 December 2020

Role of nitrates in angina pectoris

1 reference

12 December 2020

Assessment of "optimal" beta blockade in treating patients with angina pectoris

1 reference

12 December 2020

The role of calcium antagonists in the treatment of myocardial ischemia

1 reference

12 December 2020

New therapeutic modalities for the treatment of elderly patients with ischemic heart disease

1 reference

12 December 2020

Mortality in relation to smoking: 20 years' observations on male British doctors

1 reference

12 December 2020

N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin

1 reference

12 December 2020

Effect of glyceryl trinitrate on echocardiographic left ventricular dimensions during exercise in the upright position

1 reference

12 December 2020

Nicotine replacement therapy for patients with coronary artery disease. Working Group for the Study of Transdermal Nicotine in Patients with Coronary artery disease

1 reference

12 December 2020

Physiologic and pathophysiologic relevance of T-type calcium-ion channels: potential indications for T-type calcium antagonists

1 reference

12 December 2020

Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease.

1 reference

12 December 2020

Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris

1 reference

12 December 2020

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

12 December 2020

Stable angina: drugs, angioplasty or surgery?

1 reference

12 December 2020

Efficacy of mibefradil compared with amlodipine in suppressing exercise-induced and daily silent ischemia: results of a multicenter, placebo-controlled trial

1 reference

12 December 2020

Drug therapy. Combined beta-adrenergic and calcium-entry blockade in angina pectoris

1 reference

12 December 2020

Vitamin E consumption and the risk of coronary heart disease in men.

1 reference

12 December 2020

Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrate

1 reference

12 December 2020

"Maximal" drug therapy is not necessarily optimal in chronic angina pectoris

1 reference

12 December 2020

Effect of swallowed isosorbide dinitrate on blood pressure, heart rate and exercise capacity in patients with coronary artery disease

1 reference

12 December 2020

Eccentric dosing with isosorbide-5-mononitrate in angina pectoris.

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

The calcium antagonist scare in America: what have I learned?

1 reference

12 December 2020

Risk factors and noncontraceptive estrogen use in women with and without coronary disease

1 reference

12 December 2020

Daily life ischemia and nitrate therapy

1 reference

12 December 2020

Diltiazem treatment for the management of ischaemia in patients with poor left ventricular function: safety of long term administration

1 reference

12 December 2020

Comparative efficacy and safety of bepridil and diltiazem in chronic stable angina pectoris refractory to diltiazem. The Bepridil Collaborative Study Group

1 reference

12 December 2020

Medical therapy of stable angina pectoris

1 reference

12 December 2020

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

12 December 2020

Clinical trials in the secondary prevention of myocardial infarction and stroke

1 reference

12 December 2020

Postmenopausal estrogen use and coronary atherosclerosis

1 reference

12 December 2020

Beta-adrenergic blockers and intermittent claudication. Time for reappraisal

1 reference

12 December 2020

Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women.

1 reference

12 December 2020

Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)

1 reference

12 December 2020

Postmenopausal hormone therapy and mortality.

1 reference

12 December 2020

When does nitrate tolerance develop? What dosages and which intervals are necessary to ensure maintained effectiveness?

1 reference

12 December 2020

The primary prevention of myocardial infarction

1 reference

12 December 2020

Relative and Absolute Excess Risks of Coronary Heart Disease among Women Who Smoke Cigarettes

1 reference

12 December 2020

The preventative effects of vasodilating beta-blockers in cardiovascular disease

1 reference

12 December 2020

Reduced thiols and the effect of intravenous nitroglycerin on platelet aggregation

1 reference

12 December 2020

Hormone replacement therapy and cardiovascular disease: the human model

1 reference

12 December 2020

10.2165/00002018-199819010-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

12 September 2017

1044563984

0 references

Fatcat ID

release_uwb524cmhba4ff4usq5dnfzd2y

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uwb524cmhba4ff4usq5dnfzd2y

24 November 2022

mapped directly with Wikidata item

1 reference